Waters Corporation

NYSE WAT

Data sourced from

and

Download Data

Waters Corporation Net Operating Profit After Tax (NOPAT) 1 year YoY Change (%) for the Trailing 12 Months (TTM) ending March 31, 2024: -17.61%

Waters Corporation Net Operating Profit After Tax (NOPAT) 1 year YoY Change (%) is -17.61% for the Trailing 12 Months (TTM) ending March 31, 2024, a -395.58% change year over year. Net Operating Profit After Taxes (NOPAT) is a financial metric that represents a company's operating profit after deducting taxes. It is calculated by multiplying the earnings before interest and taxes (EBIT) by (1 - tax rate). NOPAT provides insights into the company's profitability from its core operations while accounting for the impact of taxes. It is useful for assessing the company's operating performance and comparing profitability across different tax environments. The measure "Change (%)" refers to the percentage change in the value of a financial metric between two time points. This measure provides a relative perspective on the magnitude of change.

Waters Corporation Net Operating Profit After Tax (NOPAT) for the Trailing 12 Months (TTM) ending March 31, 2023 was 207,790,069.79, a -3.55% change year over year.
Waters Corporation Net Operating Profit After Tax (NOPAT) for the Trailing 12 Months (TTM) ending March 31, 2022 was 215,447,679.54, a 12.79% change year over year.
Waters Corporation Net Operating Profit After Tax (NOPAT) for the Trailing 12 Months (TTM) ending March 31, 2021 was 191,021,797.69, a 15.27% change year over year.
Waters Corporation Net Operating Profit After Tax (NOPAT) for the Trailing 12 Months (TTM) ending March 31, 2020 was 165,715,493.19, a -4.43% change year over year.

NYSE: WAT

Waters Corporation

CEO	Dr. Udit Batra Ph.D.
IPO Date	Nov. 16, 1995
Location	United States
Headquarters	34 Maple Street, Milford, MA, United States, 01757
Employees	7,900
Sector	Healthcare
Industry	Diagnostics & research

Description

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Key trends